| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |